Autophagy plays an important role in maintaining the cellular homeostasis. One of its functions is to degrade unnecessary organelles and proteins for energy recycling or amino-acids for cell survival. Ablation of autophagy leads to neurodegeneration. Multiple sclerosis (MS), a permanent neurological impairment typical of chronic inflammatory demyelinating disorder, is an auto-immune disease of the central nervous system (CNS). Autophagy is tightly linked to the innate and adaptive immune systems during the autoimmune process, and several studies have shown that autophagy directly participates in the progress of MS or experimental autoimmune encephalomyelitis (EAE, a mouse model of MS). Dysfunction of mitochondria that intensively infl uences the autophagy pathway is one of the important factors in the pathogenesis of MS. Autophagy-related gene (ATG) 5 and immune-related GTPase M (IRGM) 1 are increased, while ATG16L2 is decreased, in T-cells in EAE and active relapsing-remitting MS brains. Administration of rapamycin, an inhibitor of mammalian target of rapamycin ( mTOR), ameliorates relapsing-remitting EAE. Infl ammation and oxidative stress are increased in MS lesions and EAE, but Lamp2 and the LC3-II/LC3-I ratio are decreased. Furthermore, autophagy in various glial cells plays important roles in regulating neuro-infl ammation in the CNS, implying potential roles in MS. In this review, we discuss the role of autophagy in the peripheral immune system and the CNS in neuroinfl ammation associated with the pathogenesis of MS.
Introduction
Autophagy, a lysosome-dependent degradation pathway, contributes to maintaining cellular homeostasis. Clearance of long-lived proteins, unnecessary organelles, and aggregate-prone proteins is mainly executed by autophagy for recycling cellular materials [1] . There are three subtypes Parkin and PINK1 play critical roles in this process [2] . More
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M u l t i p l e s c l e r o s i s ( M S ) i s a n o n -i n h e r i t e d neurodegenerative disease characterized by the involvement of innate and adaptive immunity. MS occurs mainly in young adults and its incidence in females is two to three times higher than that in males. About 85% of MS patients show relapse-remission before irreversible progression.
It is widely accepted that MS is an auto-immune disease caused by autoreactive T-cells that target the myelin sheath in the central nervous system (CNS) [6, 7] . These myelin demonstrates that auto-immunity is indispensable in the pathogenesis of MS [8] . Genome-wide association studies have shown that immunologically-relevant genes, especially
T-helper-cell differentiation genes, are significantly overrepresented in the pathogenesis of MS [9] . However, it is still unclear what exactly causes the disease. One of the initiators of MS is antigen from virus or bacteria that is similar to the myelin basic protein peptide [10, 11] . The autoimmunity hypothesis is now being challenged since the fi nding that, like many other neurodegenerative disorders, gray matter lesions and brain atrophy are detectable before MS onset [12, 13] . So the initiators of MS still need further
investigation. An important factor in MS development is neuro-inflammation, which is also one of the main characteristics of MS (chronic inflammation, infiltration of peripheral immune cells, demyelination, transected axons, and gliosis). The frail neurons die when they are exposed to the infl ammatory environment. Pro-infl ammatory factors such as IL17 impair the differentiation of oligodendrocyte progenitor cells (OPCs) in MS [14] .
Autophagy is tightly linked with auto-immune diseases, including MS [15] [16] [17] . The extracellular matrix molecule fibronectin aggregates in chronically demyelinating MS and the relapsig phase of EAE; it may be resistant to degradation and affect the remyelination process [18] .
Soluble oligomers have been detected in the brain and cerebral spinal fl uid of MS patients [19] . Meanwhile, oxidized protein aggregates increase in EAE, probably due to the reduced autophagy level [20] . Moreover, autophagy intensively regulates infl ammation in various diseases. To unravel the potential role of autophagy in the pathogenesis of MS, we highlight its possible importance in both the generation of auto-reactive lymphocytes and the regulation of neuro-inflammation. Differential cell-type specificity of autophagy in the peripheral immune system and the CNS might modulate the onset and progression of MS (Fig. 1 ).
Autophagy and Mitochondria in MS
Mitochondria play important roles in general and selective autophagic flux, including mitophagy. Dysfunction of mitochondria during stress is one of the important factors involved in the pathogenesis of MS and EAE. Autophagy maintains the architecture of mitochondria, restores their function, and prevents their dysfunction, which are critical for cell survival and the pathogenesis of MS [21] [22] [23] . In MS, the decreased expression of cytochrome c oxidase subunit 5b may impair the function of mitochondria [24] . Dysfunction of mitochondria produces reactive oxygen species (ROS), which contribute to demyelination and axonal loss [25] .
Autophagy clears depolarized mitochondria to reduce the excessive production of ROS by increasing BECN1 or regulating ATG4 activity [26, 27] , which is protective in MS.
Autophagy and MS in the Peripheral Immune System

Mutual Regulation of Autophagy and Infl ammation
The connections between autophagy and infl ammation are complex. Each regulates the other by different mechanisms.
Pattern-recognition receptors for pathogen recognition, such as toll-like receptors (TLRs) and NOD-like receptors (NLRs) can elicit autophagy for pathogen clearance [28] .
However, autophagy negatively regulates inflammation to prevent the harmful amplification of inflammatory factors.
For instance, ATG9 suppresses the stimulator of IFN genes protein (STING) in type-I IFN signaling to reduce the inflammatory response [29] . Blockade of autophagy leads to the activation of inflammasomes which control the proteolytic processing and secretion of IL -1β and IL-18 under infl ammatory stress [30, 31] . Also, ablation of autophagyrelated 16-like 1 (ATG16L1) increases the production of IL-1β and IL-18 in the mouse model of Crohn's disease [32] .
Moreover, infection of ATG5-defi cient myeloid cells with M.
tuberculosis increases the expression of IL-17, a potent mediator in autoimmunity [33] . In primary effective T-cells, p62 serves as a receptor for autophagic degradation of ubiquitinated BCL10 during TCR activation to protect cells from excessively activated NF-κB pathway [34] .
Inflammatory factors in turn regulate the progress of autophagy. The T-helper 1 (Th1) cell cytokine IFNγ induces autophagy in macrophages to suppress the survival of mycobacteria [35] . Another pro-inflammatory factor, Tnf, also induces autophagy in monocytes/macrophages [36] . However, the Th2 cell cytokines IL-4 and IL-13 ablate autophagy in macrophages [36] .
Autoreactive T-Cell Regulation by Autophagy
Besides innate immunity, autophagy also participates histocompatibility complex class II molecules [37, 38] . In thymic [38] . Atg7 ablation in dendritic cells (DCs), the most potent antigen-presenting cells, ameliorates EAE. Blockade of autophagy in DCs by chloroquine also delays the onset or reduces the severity of EAE [39] . DCs from patients with Crohn's disease with ATG16L1 and NOD2 variants are defective in antigen presentation [40] . The presentation of citrullinated peptides by DCs, macrophages, and thymic DCs is blocked by inhibition of autophagy with 3-methyladenine [41] .
Autophagy regulates the homeostasis, proliferation, differentiation, maturation, and apoptosis of T-cells. It also maintains the calcium flux and the pro-survival process and counteracts pro-apoptotic action to maintain T-cell homeostasis [42] [43] [44] [45] . Cyt1 induces autophagosome formation when it binds to CD46, which may function in maintaining the homeostasis of T-cells during adaptive immunity [46] .
Moreover, the expression of ATG16 L2 in T-cells is reduced, and this is likely to perturb the homeostasis of T-cells in MS [47] . ATG5 plays important roles in T-cell survival and controls the proliferation, differentiation and maturation of CD4/8 + T-cells and B-cells [48] [49] [50] . mTOR-deficient T-cells fail to differentiate into T-helper cells, Th1, Th2, and Th17 effector cells [51, 52] . ATG5 is signifi cantly elevated in T-cells in MS lesions and EAE mice compared to controls. The increase of autophagy in T-cells may promote their survival, contributing to the pathogenesis of MS [53] . Immune-related GTPase M1 is highly expressed in MS lesions in the CNS and EAE models, and contributes to the pathogenesis of MS by increasing the survival of autoreactive CD4 + T-cells [17] . Rapamycin, an inhibitor of mTOR, ameliorates the relapsing-remitting EAE (RR-EAE) in SJL/j mice by increasing the Treg cell population [54] . However, the contributions of autophagy in different T-cell populations to cell death depend on the context. Upon activation of autophagy, Th2 cells undergo growth factor-withdrawalmediated cell death [55] . The induction of autophagy through binding of HIV-1 envelope glycoproteins to CXC chemokine receptor 4 of CD4 + T-cells is necessary for apoptosis [56] .
FADD or casp8 in T-cells limits autophagy and protects
against cell necrosis and infl ammation [57, 58] . Alteration of the proportions of different T-cell groups affects the immune response [59] .
Pathological Role of Autophagy in MS
Autophagy and Neuro-infl ammation
CNS autophagy is linked with serious neurodegenerative diseases. Defi ciency of basal autophagy in neurons leads to protein aggregation and finally neurodegenerative diseases [60, 61] . Neuro-infl ammation is one of the important toxic effects on primary neurons [7, 62] . However, autophagy plays an essential role in maintaining neuro-inflammation at a harmless level. Activation of Drd1 by dopamine inhibits NOD-LRR-containing pyrin domain 3 (NLRP3)
inflammasome activation through autophagic degradation of NLRP3 via the E3 ubiquitin ligase MARCH7 [63] . The dopamine system also regulates lymphocyte activity in lupus and MS, suggesting an important role of dopamine in the regulation of peripheral or CNS infi ltrated lymphocytes during the pathogenesis of MS [64, 65] . In addition, inhibition of neuro-infl ammation by autophagy has great benefi ts on ischemia [66] . Autophagy may be a stress response to the negative feedback regulation of neuro-infl ammation. In the chronic LPS model, pro-infl ammatory factor IL-1β in cortex is positively correlated with the autophagy markers Beclin-1 and LC3-II and inversely correlated with p62 [67] .
Autophagy can be deleterious depending on the disease. Activation of the autophagic pathway in ischemia leads to the death of astrocytes and neurons, which can be rescued by autophagy inhibitors [68, 69] . Meanwhile, blockade of microglial autophagy in permanent middle cerebral artery occlusion by autophagy inhibitors reduces the severity of the disease [70] . Thus, autophagy in different diseases and cell types in the CNS seems to function differently.
Autophagic cell death is still under debate and needs further investigation [71] .
Autophagy in Glial Cells
Until recently, most studies on autophagy in the CNS focused on neurons, with less on glial cells. The activation of glial cells plays important roles in neuro-inflammation, and these cells are indispensable for the development of MS [7] . MS progression occurs between glial activation and gliosis. Autophagy in various glial cells may play a role in responding to stress in MS. Therefore, it is urgent to study the effect of glial autophagy on neurological diseases, including MS.
Microglia are the first line of defense in the CNS, monitoring exotic and intrinsic pathogens. During demyelination, cell debris is mainly phagocytized by microglia or microphages, a process that requires autophagy-related genes [72] . Impairment of autophagy in microglia may hinder debris clearance, leading to damaged remyelination and augmentation of persistent neuroinflammation. The rapid activation of microglia produces pro-infl ammatory cytokines and free radicals, and acts as the major antigen-presenting cell [73, 74] . Pro-inflammatory factors such as IL-1β can trigger microglial autophagy, suggesting links between autophagy and inflammation activation [75] . mTOR plays a pivotal role in autophagy suppression and promotes infl ammation in microglia, and rapamycin may have a beneficial effect in the treatment of MS [76] . mTOR inhibitors reduce neuro-inflammation by inhibiting microglial activation or viability, decreasing proinfl ammatory cytokines [77] . Simian immunodefi ciency virusinfected microglia attenuate the survival of neurons by inhibiting neuronal autophagy [78] , which implicates a cellcell type regulation of autophagy in the CNS. However, microglial autophagy in middle cerebral artery occlusion makes the disease worse [70] . It is possible that the role of microglial autophagy depends on the disease.
Astrocytes are the primary supportive elements for neuronal structure and neurotrophy, comprising ~50% of cells in the adult mammalian brain. Autophagy is necessary for the differentiation and maturation of astrocytes [79] , and can be initiated in inflammatory stress and may be important in the development of MS.
During pro-inflammatory stimuli, autophagy is induced to maintain mitochondrial networks [22] . Impairment of the autophagy pathway by ablation of Atg7 in astrocytes in the inflammatory environment amplifies the response to produce more neurotoxic factors such as ROS, which induces astrocytic cell death [22, 80] . mTOR in the astrocyte may play a protective role in ischemia via its downstream kinase S6K1 [81] . mTOR can also regulate the stability of iNOS mRNA in astrocytes, reducing the neurotoxic effect of NO which impairs autophagy by disrupting the BECN1 complex and activates mTORC1 [82] [83] [84] .
OPCs are indispensable during oligodendrocyte differentiation and myelin remyelination; they are activated for remyelination in MS lesions [85, 86] . They also play an important role in MS pathogenesis by modulating immune activity in the CNS. Act1 deletion in OPCs blocks the IL-17 pathway, attenuating neuro-inflammation and increasing OPC maturation [14] . OPCs can also clear β-amyloid peptides by triggering endocytosis and autophagy [87] , implying an autophagic role of OPCs in MS. However, the exact functions of OPCs in MS need further investigation, including those of autophagy and its differentiation, nutritional support, debris clearance, and inflammation regulation.
R o l e s o f A u t o p h a g y i n M S -A s s o c i a t e d Demyelination and Remyelination
Autophagy is closely linked to demyelination and remyelination. It plays potential roles in improving Schwann cell remyelination in demyelinating peripheral neuropathies [88] . Rapamycin, a potent autophagy inducer, improves myelination, leading to enhanced neuronal survival in tuberous sclerosis [89] . Meanwhile, in Long-Evans shaker rats, an increased autophagy level increases the number of myelinated axons and myelin sheath thickness during dysmyelination and demyelination, which implies that the autophagy pathway is a direct target for therapy for demyelination [90] . Furthermore, high mobility group box chromosomal protein 1 (HMGB1), which promotes autophagy, is elevated in MS and EAE [91] . However, the progression of MS and EAE involves many cell types.
Different cell types in the lesion site might show different patterns of autophagy. In MS, especially in the acute phase, nerve growth factor (NGF) is dramatically increased in the cerebrospinal fluid [92] . NGF inhibits autophagy and cell death of neurons through the p75 neurotrophin receptor, suggesting a protective role in MS [93] . In MS lesions, Lamp2 expression is reduced [94] , implying an impairment of autophagy. The mTOR signaling pathway that inhibits autophagy restores the regrowth of axons in the CNS, which is important for remyelination in MS [95, 96] .
Moreover, in acute and chronic EAE, protein aggresomes in the spinal cord and a reduced LC3-II/LC3-I ratio suggest that the protein turnover mechanism through autophagy is impaired [20] . In fact, the mechanism of autophagy in the pathogenesis of MS in the CNS is still superficially understood. Autophagy in different stages of the disease and different cell types needs further investigation to determine the causal relationship between autophagy and MS.
Conclusive Remarks
So far, little is known about the exact mechanism of autophagy in MS. It is still controversial whether autophagy leads to cell death in MS or is a rescue mechanism activated as part of an endogenous neuroprotective response, since autophagy plays opposite functions in inflammation and cell survival, depending on the context.
Drugs modifying the immune system and remyelination have been used to help with relapse management, reduce the degree of disability, and improve the quality of life [97, 98] .
The effects of rapamycin and chloroquine in the therapy of EAE shed light on the autophagy pathway as a potential target for drug development. The inhibition of autophagy in mesenchymal stem cells provides a novel strategy to improve therapeutic effects by enhancing the suppression of CD4 + T-cells [99] . In order to develop effective and more specifi c therapeutic strategies, we need to fully understand the complex interplay between autophagy and MS in different cell types.
